revona bio ltd
revona bio ltd Company Information
Company Number
14236436
Next Accounts
Jun 2026
Shareholders
the university of portsmouth
charlotte anne henderson
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
34 high street, aldridge, walsall, west midlands, WS9 8LZ
Website
revona.biorevona bio ltd Estimated Valuation
Pomanda estimates the enterprise value of REVONA BIO LTD at £838.2k based on a Turnover of £622.3k and 1.35x industry multiple (adjusted for size and gross margin).
revona bio ltd Estimated Valuation
Pomanda estimates the enterprise value of REVONA BIO LTD at £0 based on an EBITDA of £-239.5k and a 5.31x industry multiple (adjusted for size and gross margin).
revona bio ltd Estimated Valuation
Pomanda estimates the enterprise value of REVONA BIO LTD at £0 based on Net Assets of £-331.7k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Revona Bio Ltd Overview
Revona Bio Ltd is a live company located in walsall, WS9 8LZ with a Companies House number of 14236436. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2022, it's largest shareholder is the university of portsmouth with a 33.3% stake. Revona Bio Ltd is a startup, small sized company, Pomanda has estimated its turnover at £622.3k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Revona Bio Ltd Health Check
Pomanda's financial health check has awarded Revona Bio Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
6 Weak
Size
annual sales of £622.3k, make it smaller than the average company (£4.8m)
- Revona Bio Ltd
£4.8m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Revona Bio Ltd
- - Industry AVG
Production
with a gross margin of 56%, this company has a comparable cost of product (56%)
- Revona Bio Ltd
56% - Industry AVG
Profitability
an operating margin of -38.9% make it less profitable than the average company (-7%)
- Revona Bio Ltd
-7% - Industry AVG
Employees
with 7 employees, this is below the industry average (50)
7 - Revona Bio Ltd
50 - Industry AVG
Pay Structure
on an average salary of £82.9k, the company has an equivalent pay structure (£82.9k)
- Revona Bio Ltd
£82.9k - Industry AVG
Efficiency
resulting in sales per employee of £88.9k, this is less efficient (£131.5k)
- Revona Bio Ltd
£131.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Revona Bio Ltd
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (57 days)
- Revona Bio Ltd
57 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Revona Bio Ltd
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 3415 weeks, this is more cash available to meet short term requirements (32 weeks)
3415 weeks - Revona Bio Ltd
32 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 152.2%, this is a higher level of debt than the average (50.8%)
152.2% - Revona Bio Ltd
50.8% - Industry AVG
REVONA BIO LTD financials
Revona Bio Ltd's latest turnover from September 2024 is estimated at £622.3 thousand and the company has net assets of -£331.7 thousand. According to their latest financial statements, Revona Bio Ltd has 7 employees and maintains cash reserves of £470 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2024 | Sep 2023 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 7 | 4 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2024 | Sep 2023 | |
|---|---|---|
| Tangible Assets | 14,480 | 3,687 |
| Intangible Assets | ||
| Investments & Other | ||
| Debtors (Due After 1 year) | ||
| Total Fixed Assets | 14,480 | 3,687 |
| Stock & work in progress | ||
| Trade Debtors | ||
| Group Debtors | ||
| Misc Debtors | 150,629 | 93,013 |
| Cash | 470,048 | 64,823 |
| misc current assets | ||
| total current assets | 620,677 | 157,836 |
| total assets | 635,157 | 161,523 |
| Bank overdraft | ||
| Bank loan | ||
| Trade Creditors | 719 | 10,126 |
| Group/Directors Accounts | ||
| other short term finances | ||
| hp & lease commitments | ||
| other current liabilities | 6,438 | 4,076 |
| total current liabilities | 7,157 | 14,202 |
| loans | ||
| hp & lease commitments | ||
| Accruals and Deferred Income | ||
| other liabilities | 959,710 | 250,000 |
| provisions | ||
| total long term liabilities | 959,710 | 250,000 |
| total liabilities | 966,867 | 264,202 |
| net assets | -331,710 | -102,679 |
| total shareholders funds | -331,710 | -102,679 |
| Sep 2024 | Sep 2023 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | 2,929 | 941 |
| Amortisation | ||
| Tax | ||
| Stock | ||
| Debtors | 57,616 | 93,013 |
| Creditors | -9,407 | 10,126 |
| Accruals and Deferred Income | 2,362 | 4,076 |
| Deferred Taxes & Provisions | ||
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | ||
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | ||
| Group/Directors Accounts | ||
| Other Short Term Loans | ||
| Long term loans | ||
| Hire Purchase and Lease Commitments | ||
| other long term liabilities | 709,710 | 250,000 |
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 405,225 | 64,823 |
| overdraft | ||
| change in cash | 405,225 | 64,823 |
revona bio ltd Credit Report and Business Information
Revona Bio Ltd Competitor Analysis
Perform a competitor analysis for revona bio ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in WS9 area or any other competitors across 12 key performance metrics.
revona bio ltd Ownership
REVONA BIO LTD group structure
Revona Bio Ltd has no subsidiary companies.
Ultimate parent company
REVONA BIO LTD
14236436
revona bio ltd directors
Revona Bio Ltd currently has 6 directors. The longest serving directors include Dr Anastasia Callaghan (Jul 2022) and Dr Charlotte Henderson (Jul 2022).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Anastasia Callaghan | United Kingdom | 50 years | Jul 2022 | - | Director |
| Dr Charlotte Henderson | United Kingdom | 40 years | Jul 2022 | - | Director |
| Dr Jason Mellad | United Kingdom | 43 years | Oct 2022 | - | Director |
| Dr Ian Gilham | England | 65 years | Feb 2023 | - | Director |
| Dr David Sheppard | United Kingdom | 51 years | Apr 2023 | - | Director |
| Ms Mary White | United Kingdom | 52 years | Jan 2025 | - | Director |
P&L
September 2024turnover
622.3k
+77%
operating profit
-242.4k
0%
gross margin
56.1%
+4.3%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2024net assets
-331.7k
+2.23%
total assets
635.2k
+2.93%
cash
470k
+6.25%
net assets
Total assets minus all liabilities
Similar Companies
revona bio ltd company details
company number
14236436
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
July 2022
age
3
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2024
previous names
N/A
accountant
-
auditor
-
address
34 high street, aldridge, walsall, west midlands, WS9 8LZ
Bank
-
Legal Advisor
-
revona bio ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to revona bio ltd.
revona bio ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for REVONA BIO LTD. This can take several minutes, an email will notify you when this has completed.
revona bio ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
